Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
96M
Number of holders
1
Total 13F shares, excl. options
13.9K
Shares change
0
Total reported value, excl. options
$316K
Price
$22.70

Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q4 2023

1 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q4 2023.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13.9K shares of 96M outstanding shares and own 0.01% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.41M shares), FRED ALGER MANAGEMENT, LLC (3.33M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.27M shares), STATE STREET CORP (2.59M shares), VR Adviser, LLC (2.56M shares), VANGUARD GROUP INC (2.13M shares), Lynx1 Capital Management LP (2.11M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.01M shares), PERCEPTIVE ADVISORS LLC (2M shares), and Bain Capital Life Sciences Investors, LLC (2M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.